Search clinical trials for: CD8 tumor infiltrating lymphocyte (TIL)
Total 94690 results
-
AgonOx, Inc.Providence St Joseph Health; Phio Pharmaceuticals Corp.RecruitingMelanoma | Gynecologic Cancer | Colorectal Cancer | Lung Cancer | HNSCC | Urogenital CancerUnited States
-
Hellenic Cooperative Oncology GroupCompletedBladder Cancer
-
Nektar TherapeuticsImaginAb, Inc.Withdrawn
-
Dan ZandbergRecruitingRecurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)United States
-
Diwakar DavarImmunocore LtdNot yet recruitingUveal MelanomaUnited States
-
Nantes University HospitalCompletedAllergic Rhinitis | Atopic Dermatitis | Allergic AsthmaFrance
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)TerminatedSkin Cancer | Metastatic MelanomaUnited States
-
Bristol-Myers SquibbCompletedHealthy VolunteersUnited Kingdom
-
Ohio State UniversityTerminatedOsteoarthritis, KneeUnited States
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceActive, not recruitingColorectal Cancer | Surgical Resection of the Colorectal TumorFrance
-
National Cancer Institute (NCI)CompletedMelanoma | Skin Cancer | Metastatic MelanomaUnited States
-
Hebei Senlang Biotechnology Inc., Ltd.RecruitingGlioblastoma Multiforme, AdultChina
-
National University Hospital, SingaporeSingapore General HospitalUnknownAcute Myeloid Leukemia | Myelodysplastic SyndromesSingapore
-
Haukeland University HospitalInstitut National de la Santé Et de la Recherche Médicale, France; University... and other collaboratorsUnknownPermanent Neonatal Diabetes MellitusNorway
-
Shanghai Juncell TherapeuticsRecruitingAdvanced Solid Tumor | Efficacy | Immunotherapy | Adverse Drug Event | Safety | Tumor Infiltrating LymphocytesChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | HLA-A*0201 Positive Cells Present | COL6A3 Positive | PRAME PositiveUnited States
-
Huashan HospitalShanghai Cell Therapy Research InstituteActive, not recruitingGlioblastoma MultiformeChina
-
China Medical University HospitalCompletedIL-17+ CD8 T Cells in Cancer PatientsTaiwan
-
Shanghai Juncell TherapeuticsShanghai Tong Ren HospitalRecruiting
-
Imperial College LondonWithdrawnAllogeneic Stem Cell Transplantation | CMV Reactivation | Autologous CMV Specific CD8+ T CellsUnited Kingdom
-
Nurix Therapeutics, Inc.TerminatedCervical Cancer | Endometrial Cancer | Platinum-resistant Ovarian CancerUnited States
-
Centre Hospitalier Universitaire de Saint EtienneCompletedLung Cancer | SurgeryFrance
-
Institut National de la Santé Et de la Recherche...Assistance Publique - Hôpitaux de Paris; Institut PasteurCompletedInfluenza | Acute Respiratory Distress Syndrome | Acute Lung InjuryFrance
-
Cytovation ASMerck Sharp & Dohme LLCActive, not recruitingAdvanced Solid Tumor MalignancyNetherlands, France, Spain
-
CAR-T (Shanghai) Cell Biotechnology Co., Ltd.Eastern Hepatobiliary Surgery HospitalUnknown
-
Cytovation ASMerck Sharp & Dohme LLCActive, not recruitingAdvanced Breast Cancer | Advanced Melanoma | Advanced Head and Neck Squamous Cell CarcinomaUnited States, France, Italy, Spain, Netherlands
-
Immetacyte LtdWithdrawnOvarian Cancer MetastaticUnited Kingdom
-
Shanghai OriginCell Therapeutics Co., Ltd.Not yet recruitingCarcinoma, Non-Small-Cell Lung
-
Ain Shams UniversityRecruiting
-
Duke UniversityCompletedNon-small Cell Lung CarcinomaUnited States
-
Vastra Gotaland RegionNot yet recruitingMetastatic Cutaneous Melanoma | Uveal Melanoma
-
Grit BiotechnologyRecruiting
-
The Netherlands Cancer InstituteCopenhagen University Hospital at HerlevActive, not recruitingMetastatic MelanomaNetherlands, Denmark
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung CancerCanada, Netherlands, Spain, France, Japan, Russian Federation, Germany, Belgium, Greece, Turkey, Taiwan, United States
-
AstraZenecaImaginAb, Inc.TerminatedCarcinoma, Non-Small-Cell Lung | Urinary Bladder Neoplasms | Colorectal CancerUnited States, Canada
-
ImaginAb, Inc.CompletedMetastatic Solid Tumors | Positron-Emission TomographyUnited States
-
M.D. Anderson Cancer CenterEligixTerminatedCD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell TransplantationMultiple Myeloma | Chronic Lymphocytic Leukemia | Chronic Myelogenous Leukemia | Non Hodgkin's Lymphoma | Hodgkin's DiseaseUnited States
-
Saint John's Cancer InstituteTerminatedMetastatic MelanomaUnited States
-
Suzhou BlueHorse Therapeutics Co., Ltd.RecruitingMelanoma | Non Small Cell Lung Cancer | Cervical CarcinomaChina
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Stand Up To Cancer; Iovance Biotherapeutics, Inc.; Prometheus...CompletedNon-Small Cell Lung Cancer | Adenocarcinomas | Squamous Cell Carcinoma | Advanced NSCLC | Metastatic Non-small Cell Lung Cancer | Adenosquamous CarcinomaUnited States
-
Shanghai Juncell TherapeuticsRecruitingMelanoma | Efficacy | Adverse Drug Event | Safety | Tumor Infiltrating LymphocytesChina
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Neal ReadyMerck Sharp & Dohme LLCActive, not recruiting
-
King's College LondonRecruitingDepression | Anxiety | Mental Health IssueUnited Kingdom
-
Sizhen WangShanghai Biomed-union Biotechnology Co., Ltd.RecruitingAdvanced Pancreatic CancerChina
-
Centre Georges Francois LeclercActive, not recruiting
-
Yale UniversityTerminatedMetastatic MelanomaUnited States
-
Sun Yat-sen UniversityActive, not recruiting
-
AmgenCompletedUnresected Stage IIIb to IVM1c MelanomaFrance, Poland, Italy, Russian Federation, Netherlands, Spain, United States, Austria, Belgium, United Kingdom, Germany, Hungary, Greece